[Pulmonary surfactants].
D000367:Age Factors; D002245:Carbon Dioxide; D006025:Glycosaminoglycans / Q000032:analysis; D006801:Humans; D006819:Hyaline Membrane Disease / Q000473:pathology; D007231:Infant, Newborn; D008055:Lipids / Q000032:analysis; D008854:Microscopy, Electron; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects; D011506:Proteins / Q000032:analysis; D001261:Pulmonary Atelectasis / Q000473:pathology; D011654:Pulmonary Edema / Q000473:pathology; D011663:Pulmonary Surfactants / Q000032:analysis; D012127:Respiratory Distress Syndrome, Newborn / Q000473:pathology; D012907:Smoking; D013499:Surface Properties
D006025:Glycosaminoglycans; D008055:Lipids; D011506:Proteins; D011663:Pulmonary Surfactants; D002245:Carbon Dioxide
Les surfactants pulmonaires.